Literature DB >> 1287223

The role of cytokines in cancer cachexia.

L L Moldawer1, M A Rogy, S F Lowry.   

Abstract

There is, at present, considerable interest in the possible role for the proinflammatory cytokines, tumor necrosis factor-alpha, interleukin-1, interleukin-6, and interferon-gamma in the pathogenesis of cancer cachexia. Indirect evidence for such a role is based on the observation that chronic administration of many of these cytokines, either alone or in combination, can reproduce the myriad of host responses seen in experimental and human cancer cachexia. Elevated plasma levels of tumor necrosis factor-alpha, interleukin-2, and interferon-gamma have rarely been detected in patients or experimental animals with cancer, although interleukin-6 levels appear to correlate with tumor progression in animal models. The strongest evidence for a causal role for cytokines has come from rodent studies in which tumor-bearing animals have been passively immunized with antibodies directed against individual cytokines. Several groups have shown modest but significant improvements in food intake and lean tissue retention with antibodies directed against tumor necrosis factor-alpha, interleukin-1, interleukin-6, and interferon-gamma. However, there has been no consistent finding that one cytokine is universally involved in cancer cachexia in histologically distinct tumor models. One ominous finding in several tumor models has been that the endogenous production of cytokines appears to support tumor growth. Such findings raise the intriguing possibility that these cytokines, although contributors to tissue wasting and anorexia, may also serve the tumor as either direct or indirect cell growth factors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287223     DOI: 10.1177/014860719201600602

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  15 in total

1.  Cachexia and anorexia.

Authors:  G Mantovani
Journal:  Support Care Cancer       Date:  2000-11       Impact factor: 3.603

Review 2.  Managing cancer-related anorexia/cachexia.

Authors:  G Mantovani; A Macciò; E Massa; C Madeddu
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Anorexia in cancer: role of feeding-regulatory peptides.

Authors:  Simona Perboni; Akio Inui
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

4.  Fighting cancer cachexia--what about today's armory?

Authors:  G Delmore
Journal:  Support Care Cancer       Date:  1993-11       Impact factor: 3.603

5.  Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.

Authors:  R Roubenoff; R A Roubenoff; J G Cannon; J J Kehayias; H Zhuang; B Dawson-Hughes; C A Dinarello; I H Rosenberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

6.  Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats.

Authors:  Carolina Campos Lima Moreira; Priscila Cassolla; Ana Paula Segantini Dornellas; Hely de Morais; Camila Oliveira de Souza; Glaucia Regina Borba-Murad; Roberto Barbosa Bazotte; Helenir Medri de Souza
Journal:  Int J Exp Pathol       Date:  2013-02       Impact factor: 1.925

7.  Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.

Authors:  S-S Yeh; S Lovitt; M W Schuster
Journal:  J Nutr Health Aging       Date:  2009-05       Impact factor: 4.075

Review 8.  Pathophysiology of cancer cachexia.

Authors:  U Keller
Journal:  Support Care Cancer       Date:  1993-11       Impact factor: 3.603

9.  Associations between quality of life, fatigue, and cytokine levels in patients aged 50+ with acute myeloid leukemia.

Authors:  Abbas H Panju; Ali Danesh; Mark D Minden; David J Kelvin; Shabbir M H Alibhai
Journal:  Support Care Cancer       Date:  2008-10-18       Impact factor: 3.603

10.  The presence of tumor necrosis factor-alpha and its antibody in the sera of cachexic patients with gastrointestinal cancer.

Authors:  T Kiyama; M Onda; A Tokunaga; I Fujita; T Okuda; T Mizutani; N Matsukura; Y Todome; H Ohkuni
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.